GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bullfrog AI Holdings Inc (NAS:BFRG) » Definitions » GF Value

Bullfrog AI Holdings (Bullfrog AI Holdings) GF Value : $0.00 (As of Jun. 07, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Bullfrog AI Holdings GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-07), Bullfrog AI Holdings's share price is $2.71. Bullfrog AI Holdings's GF Value is $0.00. Therefore, Bullfrog AI Holdings's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Bullfrog AI Holdings is Not Valued.


Bullfrog AI Holdings  (NAS:BFRG) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Bullfrog AI Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=2.71/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bullfrog AI Holdings GF Value Related Terms

Thank you for viewing the detailed overview of Bullfrog AI Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bullfrog AI Holdings (Bullfrog AI Holdings) Business Description

Traded in Other Exchanges
N/A
Address
325 Ellington Boulevard, Unit 317, Gaithersburg, MD, USA, 20878
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
Executives
William Enright director 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG MD 20878
R Don Elsey director 2273 RESEARCH BLVD, SUITE 400, ROCKVILLE MD 20850
Dane R Saglio officer: Chief Financial Officer
Jason David Hanson director 8125 NORTH HAYDEN ROAD, SCOTTSDALE AZ 85258-2463
Vininder Singh director, 10 percent owner, officer: Chief Executive Officer 4 BLACK KETTLE COURT, BOYDS MD 20841